Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06558409 · ClinicalTrials.gov registry record · NA
Safer Still (Exploratory Project 3)
A NA study of Suicide Prevention, sponsored by Jeff Bridge.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT06558409: Recruiting NA study of Suicide Prevention, sponsored by Jeff Bridge.
NCT06558409 is a NA study of Suicide Prevention that is actively recruiting participants, run by Jeff Bridge. The registered enrollment target is 80 participants, below the 949-participant average among 21 other Suicide Prevention trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06558409, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by Jeff Bridge.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The long-term goal is to decrease suicide and suicidal behaviors in at-risk youth through preventative interventions. Investigators propose to develop an interactive intervention ("Safer Still") to help promote safe storage of firearms during the critical period immediately following high-risk care transitions. The objective of this study is to develop and test the Safer Still intervention as an efficient adjunct to traditional care for adolescents aged 12-17 years who are discharged from psychiatric hospitals and living in households where firearms are stored unsafely.
Primary Outcome
The Household Lethal Means Survey (HLMS) asks the parent to indicate whether there are any guns kept in or around the home, and if so to describe how the gun(s) and ammunition are stored. The HLMS will be supplemented with three questions from the 2018 California Safety and Well-Being Survey. These three questions address reasons for firearm ownership, loaded handgun carrying in the past 30 days, and high-capacity magazine ownership. At follow-up, the study survey assesses whether and how firear
Conditions Studied
Interventions
- BEHAVIORAL " Safer Still " Interactive Intervention
- OTHER Enhanced Usual Care (EUC):
Study Locations (2)
Ohio
- Nationwide Children's Hospital - Columbus
- Nationwide Children's Hospital Behavioral Health Pavillion - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-11-07 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT06558409 shows while recruiting
NCT06558409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 949-participant average among 21 other Suicide Prevention trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 2 interventions - of which " Safer Still " Interactive Intervention is the first listed.
NCT06558409 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06558409 about?
NCT06558409 is a clinical study titled "Safer Still (Exploratory Project 3)". The long-term goal is to decrease suicide and suicidal behaviors in at-risk youth through preventative interventions. Investigators propose to develop an interactive intervention ("Safer Still") to help promote safe storage of firearms during the critical period immediately following high-risk care ...
What is the current status of trial NCT06558409?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-11-07. Estimated completion is 2027-07-31.
What conditions does trial NCT06558409 study?
This clinical trial studies the following conditions: Suicide Prevention.
What interventions are being tested in trial NCT06558409?
The interventions under investigation include: " Safer Still " Interactive Intervention (BEHAVIORAL), Enhanced Usual Care (EUC): (OTHER).
Who is sponsoring clinical trial NCT06558409?
This trial is sponsored by Jeff Bridge, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06558409 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06558409's enrollment target sits among peer trials
80 17th of 21 higher than 5 of 21 other Suicide Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Virtual Reality Lethal Means Safety Training
RECRUITING · NA
-
Efficacy-Implementation Study for PC CARES in Rural Alaska
RECRUITING · NA
-
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
RECRUITING · NA
-
Suicide Prevention After Community Care Discharge
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI